한글목차

세계의 효소 상처 괴사조직제거 시장은 2024년에 11억 9,000만 달러로 평가되었으며, 2030년까지 CAGR 6.77%로 성장하여 17억 6,000만 달러에 달할 것으로 예측됩니다.

효소 상처 괴사조직제거는 외인성 효소를 국소적으로 도포하여 상처 부위에서 괴사 조직이나 생존 불가능한 조직을 선택적으로 제거함으로써 자연 치유 과정을 촉진하는 치료법입니다. 시장 확대는 주로 당뇨병성 족부궤양 및 욕창과 같은 만성 상처의 전 세계 유병률 증가와 상처 치유 장애 위험이 높은 고령 인구의 증가에 의해 주도되고 있습니다.

주요 시장 촉진요인

만성 상처의 유병률 증가는 전 세계 효소 상처 괴사조직제거 시장을 크게 견인하고 있습니다. 당뇨병성 족부궤양, 욕창, 정맥성 하지궤양 등의 병증에서는 비생존 조직을 제거하고 치유를 촉진하기 위해 효과적인 괴사조직제거가 필요합니다.

주요 시장 과제

세계 효소 상처 괴사조직제거 시장 확대의 가장 큰 장벽은 대체 괴사조직제거 방식에 비해 상대적으로 높은 비용으로 인해 시장 확대에 걸림돌로 작용하고 있습니다. 이러한 높은 가격 설정은 특히 예산 제약이 주요 관심사인 비용 중심의 의료 환경에서 채택률에 직접적인 영향을 미칩니다.

주요 시장 동향

기존의 입원 중심의 병원 환경에서 외래 진료 및 재택 치료 모델로의 전환이 진행되고 있는 것은 전 세계 효소 상처 괴사조직제거 시장의 중요한 트렌드입니다. 이러한 전환은 환자의 편의성 향상과 비용 절감에 대한 요구로 인해 추진되고 있습니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 효소 상처 괴사조직제거 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 종류별(만성 상처, 급성 상처)
  • 제품별(콜라게나아제 제품, 파파인 제품, 기타)
  • 용도별(병원, 재택의료, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 효소 상처 괴사조직제거 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 효소 상처 괴사조직제거 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 효소 상처 괴사조직제거 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 효소 상처 괴사조직제거 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 효소 상처 괴사조직제거 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 효소 상처 괴사조직제거 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Convatec Limited
• Smith & Nephew Plc
• Molnlycke Health Care AB
• Integra LifeSciences Corporation
• SolasCure Limited
• B. Braun SE
• Healthpoint, Ltd
• MediWound Ltd.
• 3M Company
• HARTMANN UK&I

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Enzymatic Wound Debridement Market, valued at USD 1.19 Billion in 2024, is projected to experience a CAGR of 6.77% to reach USD 1.76 Billion by 2030. Enzymatic wound debridement involves the topical application of exogenous enzymes to selectively remove necrotic or non-viable tissue from a wound bed, thereby facilitating the natural healing process. The market's expansion is primarily driven by the increasing global prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, alongside a growing geriatric population more susceptible to impaired wound healing.

Key Market Drivers

The increasing prevalence of chronic wounds significantly drives the global enzymatic wound debridement market. Conditions such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers require effective debridement to remove non-viable tissue and promote healing. The growing incidence of chronic diseases and an aging global population contribute directly to this patient demographic, creating a sustained demand for advanced wound care solutions.

Key Market Challenges

A significant impediment to the expansion of the global enzymatic wound debridement market is the comparatively high cost of these products relative to alternative debridement methods. This elevated pricing directly impacts adoption rates, particularly within cost-sensitive healthcare environments where budget constraints are a primary concern. Healthcare providers and institutions often prioritize cost-effectiveness, leading them to opt for less expensive debridement techniques despite the potential clinical benefits of enzymatic options.

Key Market Trends

The increasing shift from traditional inpatient hospital settings to outpatient clinics and home-based care models represents a significant trend in the global enzymatic wound debridement market. This transition is driven by desires for improved patient comfort and cost reduction.

Key Market Players

• Convatec Limited
• Smith & Nephew Plc
• Molnlycke Health Care AB
• Integra LifeSciences Corporation
• SolasCure Limited
• B. Braun SE
• Healthpoint, Ltd
• MediWound Ltd.
• 3M Company
• HARTMANN UK&I

Report Scope:

In this report, the Global Enzymatic Wound Debridement Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Enzymatic Wound Debridement Market, By Type:

• Chronic Wounds
• Acute Wounds

Enzymatic Wound Debridement Market, By Product:

• Collagenase Product
• Papain Product
• Others

Enzymatic Wound Debridement Market, By End Use:

• Hospitals
• Homecare
• Others

Enzymatic Wound Debridement Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Enzymatic Wound Debridement Market.

Available Customizations:

Global Enzymatic Wound Debridement Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Enzymatic Wound Debridement Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Chronic Wounds, Acute Wounds)
  • 5.2.2. By Product (Collagenase Product, Papain Product, Others)
  • 5.2.3. By End Use (Hospitals, Homecare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Enzymatic Wound Debridement Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Enzymatic Wound Debridement Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Enzymatic Wound Debridement Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Enzymatic Wound Debridement Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End Use

7. Europe Enzymatic Wound Debridement Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Enzymatic Wound Debridement Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Enzymatic Wound Debridement Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Enzymatic Wound Debridement Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Enzymatic Wound Debridement Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Enzymatic Wound Debridement Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End Use

8. Asia Pacific Enzymatic Wound Debridement Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Enzymatic Wound Debridement Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Enzymatic Wound Debridement Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Enzymatic Wound Debridement Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Enzymatic Wound Debridement Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Enzymatic Wound Debridement Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Enzymatic Wound Debridement Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Enzymatic Wound Debridement Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Enzymatic Wound Debridement Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Enzymatic Wound Debridement Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End Use

10. South America Enzymatic Wound Debridement Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Enzymatic Wound Debridement Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Enzymatic Wound Debridement Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Enzymatic Wound Debridement Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Enzymatic Wound Debridement Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Convatec Limited
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Smith & Nephew Plc
• 15.3. Molnlycke Health Care AB
• 15.4. Integra LifeSciences Corporation
• 15.5. SolasCure Limited
• 15.6. B. Braun SE
• 15.7. Healthpoint, Ltd
• 15.8. MediWound Ltd.
• 15.9. 3M Company
• 15.10. HARTMANN UK&I

16. Strategic Recommendations

17. About Us & Disclaimer